Skip to main content

FDA Registration Assistance

FDA Import Alert 54-15 kratom Mitragyna speciosa supplements
FDA Import Alerts · Dietary Supplements
Last updated:

FDA Import Alert 54-15: Kratom Supplements and Ingredients

Import Alert 54-15 lets FDA detain dietary supplements and bulk ingredients that are or contain kratom (Mitragyna speciosa) from listed firms without examining them. FDA considers kratom a new dietary ingredient with no adequate safety evidence. Capsules, leaf powder, teas, extracts and 7-OH tablets are on it. Unlike most alerts, there is rarely a path for a product that really contains kratom.

Short answer: FDA Import Alert 54-15 allows detention without physical examination of dietary supplements and bulk dietary ingredients from listed firms that are or contain kratom (Mitragyna speciosa). FDA considers kratom a new dietary ingredient with inadequate information to show it does not present a significant or unreasonable risk of illness or injury, so these products are adulterated under section 402(f)(1)(B). The alert gives no removal path for products that contain kratom; the realistic options are showing a product does not contain it or not importing it.

Listed on 54-15? Send us the firm name, product and FDA notice. We review whether the listing is correct and what options you have.

Get a 54-15 Case Review
At a Glance

Import Alert 54-15 Basics

ItemImport Alert 54-15
Official titleDWPE of Dietary Supplements and Bulk Dietary Ingredients That Are or Contain Mitragyna speciosa or Kratom
BasisNew dietary ingredient under section 413(d) with no adequate safety information
ChargeSection 402(f)(1)(B), refusal under 801(a)(3); code UNSFDIETSP
FormsCapsules, leaves, powders, resins, extracts, liquids and tablets
CountriesCanada, Indonesia, Malaysia, Philippines, Thailand, United States
Related alertImport Alert 66-41 for products marketed as drugs

Details follow the current text of Import Alert 54-15, published August 17, 2026.

Listed Products

Kratom Products Listed Under 54-15

Capsules and tablets

Kratom capsules and 7-OH tablets.

Leaf powder

Crushed and powdered dried leaves.

Whole and dried leaf

Whole, processed and dried leaves.

Kratom tea

Teas made from kratom leaf.

Extracts

Leaf extracts, resins and mitragynine extract.

Bulk liquids

Bulk liquids made from leaf extracts.

Names FDA Lists

Other Names for Kratom on the Alert

  • Mitragyna speciosa, Nauclea speciosa, nauclea and mitragynine extract.
  • Ketum, kratum, krathom, krton, cratom and gratom.
  • Biak-biak, ithang, thang, kakuam, katawn and kedemba.
  • Mambog, madat and Maeng da leaf.
  • Products labeled or promoted to treat or prevent disease may also fall under drug Import Alert 66-41.
Release and Removal

Two Tracks: Releasing a Shipment vs Leaving the List

Release one shipment

The alert gives no release route for products that contain kratom. If you believe a detained product does not contain kratom, send the FDA Division compliance office in the notice the formulation, supplier documents and lab identity testing. Otherwise the usual outcomes are export or destruction under FDA supervision.

Removal from the Red List

The alert sets no removal criteria. FDA's general guidance in RPM Chapter 9-8 applies: the firm must show the conditions behind the listing are resolved, for example that it no longer ships kratom products to the U.S. or that a listed product was misidentified. Requests can go to Importalerts2@fda.hhs.gov.

Removal Evidence

What a Strong 54-15 Request Includes

  • The Red List entry and the products named in it.
  • Full formulation and botanical identity documents for each product.
  • Lab identity testing showing the product does not contain kratom, if that is your case.
  • A written statement and records showing kratom products are no longer exported to the U.S.
  • Labels and marketing materials free of drug claims.
How It Works

Our Import Alert 54-15 Process

1
Confirm the listingWe check the Red List entry and the product named.
2
Honest assessmentWe tell you whether there is a realistic path.
3
Identity evidenceWe organize formulation, supplier and test records if the product is not kratom.
4
Detained shipmentsWe explain the export and destruction options.
5
Request and follow-upWhere justified, we send the request and answer FDA questions.

FDA's framework is in RPM Chapter 9-8; FDA removal guidance explains what a request should include.

Related Help

Import Alert Resources

Import Alert Removal

Removal help for food and supplements.

Import Alert 54-18

New dietary ingredients.

Import Alert 54-16

Supplements with hidden drugs.

Dietary Supplements

Supplement registration and labeling.

Supplement Label Review

Check claims and ingredient labeling.

Release a Held Shipment

FDA hold statuses and release steps.

Start With the Listing

Get Help With Import Alert 54-15

We review whether the listing is correct, explain the realistic options for detained shipments and prepare a request where one is justified. We are an independent compliance firm, not FDA or a law firm, and no one can guarantee FDA's decision.

  • Custom-scoped quote based on your listing and products.
  • Exporters, manufacturers and U.S. importers.
  • Agree the scope and pricing before any paid work begins.

Contact our specialists, email info@fdaregistrationassistance.com, or call +1 (928) 275-8333. Import alert removal · Supplement services · Contact.

Get a 54-15 Case Review

FDA Registration Assistance is a private consulting firm, not FDA or any government agency. FDA registration is not FDA approval, clearance or certification.

FAQ

Frequently Asked Questions — Import Alert 54-15

What is FDA Import Alert 54-15?

Import Alert 54-15 is titled "Detention Without Physical Examination of Dietary Supplements and Bulk Dietary Ingredients That Are or Contain Mitragyna speciosa or Kratom." It lets FDA detain listed kratom products without examining each shipment.

Why does FDA detain kratom supplements?

FDA considers kratom a new dietary ingredient, because it knows of no evidence it was marketed as a dietary ingredient in the U.S. before October 15, 1994, and finds no adequate evidence it can be reasonably expected to be safe. The alert cites literature on toxicity in multiple organ systems and serious side effects.

What is the charge under Import Alert 54-15?

The product appears to be a dietary supplement or contain a new dietary ingredient with inadequate information to provide reasonable assurance it does not present a significant or unreasonable risk of illness or injury. It is adulterated under section 402(f)(1)(B) and subject to refusal under section 801(a)(3). The OASIS code is UNSFDIETSP.

What other names does 54-15 cover?

Mitragyna speciosa, mitragynine extract, biak-biak, cratom, gratom, ithang, kakuam, katawn, kedemba, ketum, krathom, krton, mambog, madat, Maeng da leaf, nauclea, Nauclea speciosa and thang.

Which kratom products are on 54-15?

Capsules, whole and processed leaves, leaf resins, extracts, powdered leaves, bulk liquids made from leaf extracts, kratom teas and 7-OH tablets.

Which countries are on Import Alert 54-15?

The Red List covers six countries: Canada, Indonesia, Malaysia, the Philippines, Thailand and the United States.

How do I know if my firm is on Import Alert 54-15?

Open Import Alert 54-15 and search the Red List by country and firm name. Each entry shows the product and the date it was added. Check before every shipment season, since the alert is updated often.

Can a detained kratom shipment be released?

The alert gives no release route for products that contain kratom. If a product does not actually contain kratom, you can send the FDA Division compliance office the formulation, supplier documents and identity testing. Otherwise the shipment is usually exported or destroyed under FDA supervision.

Can an NDI notification make kratom legal as a supplement?

The alert does not describe that route, and FDA states it has no information establishing kratom's safety as a dietary ingredient. For how FDA handles other unsafe new dietary ingredients, see Import Alert 54-18.

How do I get removed from Import Alert 54-15?

The alert sets no removal criteria. Under FDA's general guidance in RPM Chapter 9-8, the firm must show the conditions behind the listing are resolved, for example that a listed product was misidentified or that it no longer ships kratom products to the U.S.

Can kratom products also be treated as drugs?

Yes. The alert tells FDA staff to watch for labeling or marketing suggesting kratom products are unapproved or misbranded drugs, and notes that Import Alert 66-41 may apply.

Does 54-15 cover 7-OH products?

The Red List includes a 7-OH tablet product. Products containing kratom compounds marketed as supplements can be detained under this alert.

Who do I contact at FDA about Import Alert 54-15?

The alert lists the Division of Import Operations at (301) 796-0356 or Imports@fda.hhs.gov, FDAPRIVATELABIMPORTALERTS@fda.hhs.gov for science and method questions, and HFP-OCE-Imports@fda.hhs.gov for policy questions.

Can you help us import kratom?

We can review whether a listing is correct and explain your options, but we cannot help get kratom products into the U.S. as dietary supplements while FDA's position stands. We will tell you plainly if there is no realistic path.

Can you guarantee removal from Import Alert 54-15?

No. FDA makes every removal decision. We are an independent compliance firm, not FDA or a law firm. We help you build a complete, well-documented request.

HM
Reviewed By Hector Matos, Senior Regulatory Compliance Specialist · 15+ years FDA compliance experience · Updated October 2026
Discuss Your Project

Request an Import Alert 54-15 Case Review

Tell us what your company makes, sells, or distributes, where each product is manufactured or packed, your U.S. importer or buyer arrangement, label readiness, and target shipment date.

Submitting this inquiry does not purchase a service or authorize paid work. Our team can discuss the scope and required materials before you commission assistance. Fields marked with an asterisk are required.

Please do not include payment details, medical records, or other sensitive information. You can also email our team or call +1 (928) 275-8333.